Bicara Therapeutics Inc (BCAX) insider trading
Every open-market stock purchase and sale by Bicara Therapeutics Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Ryan Cohlhepp (CEO) and 2 others sold $1.6M in the last 90 days.
- Last insider buy: Ra Capital Management L.p. (Insider), $35.2M, 8 months ago.
Last 12 months: insiders bought $40M (1 buy) and sold $9.9M (33 sales). Last close $17.91 on Oct 21, 2026.
Recent BCAX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 8, 2026 | Ryan Cohlhepp (CEO) | Sold | $320K |
| Sep 8, 2026 | Ryan Cohlhepp (CEO) | Sold | $80.7K |
| Sep 8, 2026 | Ryan Cohlhepp (CEO) | Bought (not open market) | $66.3K |
| Sep 8, 2026 | Ryan Cohlhepp (CEO) | Bought (not open market) | — |
| Aug 12, 2026 | Jennifer Larson (CFO) | Bought (not open market) | — |
| Aug 10, 2026 | Ryan Cohlhepp (COO) | Sold | $525K |
| Aug 10, 2026 | Ivan Hyep (CFO) | Sold | $350K |
| Aug 10, 2026 | Claire Mazumdar (CEO) | Sold | $280K |
| Aug 10, 2026 | Ryan Cohlhepp (COO) | Bought (not open market) | $71.1K |
| Aug 10, 2026 | Ivan Hyep (CFO) | Bought (not open market) | $47.4K |
| Aug 10, 2026 | Claire Mazumdar (CEO) | Bought (not open market) | $37.9K |
| Aug 10, 2026 | Ivan Hyep (CFO) | Bought (not open market) | — |
| Aug 10, 2026 | Claire Mazumdar (CEO) | Bought (not open market) | — |
| Aug 10, 2026 | Ryan Cohlhepp (COO) | Bought (not open market) | — |
| Jul 28, 2026 | Jeremy Bender (Director) | Bought (not open market) | — |
| Jul 28, 2026 | Christy J. Oliger (Director) | Bought (not open market) | — |
| Jul 10, 2026 | Claire Mazumdar (CEO) | Sold | $283K |
| Jul 10, 2026 | Claire Mazumdar (CEO) | Bought (not open market) | $37.9K |
| Jul 10, 2026 | Claire Mazumdar (CEO) | Sold | $831 |
| Jul 10, 2026 | Claire Mazumdar (CEO) | Bought (not open market) | — |
| Jul 9, 2026 | Ryan Cohlhepp (COO) | Sold | $15.5K |
| Jul 8, 2026 | Ryan Cohlhepp (COO) | Sold | $657K |
| Jul 8, 2026 | Ivan Hyep (CFO) | Sold | $651K |
| Jul 8, 2026 | Ivan Hyep (CFO) | Sold | $132K |
| Jul 8, 2026 | Ryan Cohlhepp (COO) | Sold | $128K |
Who's trading BCAX
- Ryan Cohlhepp, COO: sold $3.5M (23 sales), last Sep 8, 2026
- Jennifer Larson, CFO: other filings, last Aug 12, 2026
- Ivan Hyep, CFO: sold $2.6M (13 sales), last Aug 10, 2026
- Claire Mazumdar, CEO: sold $3.1M (14 sales), last Aug 10, 2026
- Jeremy Bender, Director: other filings, last Jul 28, 2026
- Christy J. Oliger, Director: other filings, last Jul 28, 2026
- Scott M. Robertson, Director: other filings, last Jun 9, 2026
- Christopher Bowden, Director: other filings, last Jun 9, 2026
- Kate Haviland, Director: other filings, last Jun 9, 2026
- Kiran Mazumdar-Shaw, Insider: other filings, last Jun 9, 2026
- Michael Powell, Director: other filings, last Jun 9, 2026
- Ra Capital Management L.p., Insider: bought $40M (2 buys), last Jun 9, 2026
- Jake Simson, Director: other filings, last Jun 9, 2026
- William Schelman, C-suite exec: other filings, last May 8, 2026
- David Raben, C-suite exec: sold $741K (7 sales), last Apr 27, 2026
Get free alerts when an insider at Bicara Therapeutics Inc files a new trade →